Media |

Representative Kuster Cosponsors IAVA-Backed Cannabis Research Legislation

WASHINGTON, DC (March 14, 2018)Iraq and Afghanistan Veterans of America (IAVA), the leading voice of the Post-9/11 generation of veterans, is proud to announce that U.S. Rep. Ann McLane Kuster (D-NH) has become a cosponsor of the VA Medicinal Cannabis Research Act (S. 179/H.R. 712). Rep. Kuster became a co-sponsor during IAVA’s Storm The Hill – IAVA’s quarterly advocacy push in Washington, DC.

The legislation authorizes the VA to conduct research into the safety and effectiveness of medical cannabis as a treatment for veterans with chronic pain, PTSD, and other conditions. It also requires the VA to report to Congress at least yearly on the implementation of the research.

Congresswoman Ann McLane Kuster was first elected to the House of Representatives in 2012. She is the daughter of a World War II veteran and former Prisoner of War. She currently sits on the Committee on Veterans’ Affairs, which has oversight over the VA, as well as the Small Business and Agriculture Committees.

“Since 2017, IAVA has made it one of our top priorities to empower veterans who are calling for the medicinal use of cannabis to treat the wounds of war,” said IAVA CEO Jeremy Butler. “We appreciate Rep. Kuster’s support for advancing this bipartisan bill that simply begins research at the VA to determine whether medicinal cannabis use is effective and if it is safe.”

The VA Medicinal Cannabis Research Act, sponsored by Sens. Jon Tester (D-MT) and Dan Sullivan (R-AK), now has 4 Senate cosponsors, plus 46 in the House. The bill is among IAVA’s Big Six priorities for 2019, including Suicide Prevention, Government Reform, #SheWhoBorneTheBattle, #DefendTheGIBill, and Burn Pits/Toxic Exposure Injury Support.


Media |

Support Veterans Today

Our country has an obligation to fulfill its promise to honor and support vets. Make a donation today to help IAVA fulfill its mission to connect, unite, and empower post-9/11 veterans.